Form 4: Corcept Therapeutics Executive Gary Robb Reports Stock Transfers and Holdings
SEC Form 4 Filing
Chief Business Officer Gary Charles Robb reported gifting shares and holding shares in custodial accounts for a child.
Summary
- Gary Charles Robb, Chief Business Officer of Corcept Therapeutics, filed a Form 4 detailing changes in beneficial ownership.
- On September 17, 2024, Robb gifted 300 shares of common stock.
- On September 18, 2024, Robb gifted 870 shares of common stock.
- Also on September 18, 2024, 7,250 shares were transferred from a custodial account to the child's personal account.
- Following these transactions, Robb directly owns 22,772 shares and indirectly owns 9,250 shares in custodial accounts for a child.
- The direct holdings include 638, 697, 1,818 and 503 shares underlying unvested restricted stock awards granted on December 1, 2023, March 1, 2024, June 3, 2024 and September 3, 2024 respectively, which vest on the one-year anniversary of the grant date.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock ownership and transfers. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly reducing the executive's direct holdings.
- The transfer of shares to the child's personal account could be seen as a long-term investment in the company.
Key Dates
| Date | Description |
|---|---|
| 2023-12-01 | Grant date of 638 unvested restricted stock awards. |
| 2024-03-01 | Grant date of 697 unvested restricted stock awards. |
| 2024-06-03 | Grant date of 1,818 unvested restricted stock awards. |
| 2024-09-03 | Grant date of 503 unvested restricted stock awards. |
| 2024-09-17 | Date of gifting 300 shares of common stock. |
| 2024-09-18 | Date of gifting 870 shares of common stock and transfer of 7,250 shares from custodial account. |
| 2024-09-19 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.